Fundraising Fox

Xerys

Private equity

Paris · Seed–Late Stage

Fox Verdict
Sign up to see your fit

Investment thesis

Xerys is a fully independent private equity portfolio management firm founded in 2014 that places the entrepreneur's vision at the center of its investment philosophy. It supports the managers of its portfolio companies at every stage of growth, from venture capital through to maturity, building close, constructive, and proactive relationships to advise them on strategic decisions, trade-offs, and value creation. The firm writes tickets of €15-90M and holds a concentrated portfolio of six companies. Its investment focus spans two sectors: health and sustainable development, aiming to foster shared, medium-term value creation between managers and investors.

Source: firm website, verified Aug 2, 2026.

Stage
Seed–Late Stage
Check
$16M – $97M
HQ
Paris, FR
Leads rounds
Leads
Instruments
Equity
Founded
2014
Tracked investments
8

Investments · 8 tracked

founders shown can be your intro path
Advanced BioDesign

Biotech developing ABD-3001, treating relapsed/refractory T-cell acute lymphoblastic leukemia.

AlzProtect
Biolog-id
Cryo Pur
Optionizr
PowiDian
Sevenhugs
Skytech

Company launching a line of regenerated polypropylene.

Frequently asked questions

What stage does Xerys invest at?
Xerys invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What is Xerys's typical check size?
Xerys typically writes checks of $16M – $97M.
What sectors does Xerys focus on?
Xerys focuses on Biotech, Circular Economy, Cleantech, Climate Tech, Healthtech, Medical Devices.
Where is Xerys located?
Xerys is headquartered in Paris, FR.
Does Xerys lead rounds?
Yes, Xerys leads investment rounds.

Similar investors

Featured in lists